PTK2 and cancer: In addition, according to Grace et al., during epithelial cell migration, the complex formed by EGFR and FAK has a common downstream Ezrin, and FAK and/or Ezrin could be targeted and/or used in combination with EGFR to overcome the resistance of cancer cells to EGFR-TKI in the future.